International cooperation

Metabolic R&D platform for preclinical drug development

21.3.2014   |   International cooperation

A privately owned Hungarian SME is offering innovative and cost-effective preclinical R&D services focusing on metabolic diseases (diabetes, hyperlipidemia, atherosclerosis, obesity, uremia) efficacy, safety, and pharmacokinetic animal models, including co-morbidity, custom designed and large animal models as well.


Antibody development against hard-to-produce antigens

19.3.2014   |   International cooperation

A Belgian SME has developed a novel immunization method that generates efficient antibodies without using recombinant proteins or purified proteins


Insect attractant compositions for moth pest species

17.3.2014   |   International cooperation

A South East UK University has patented an attractant composition suitable for attracting Lepidopterous insects, particularly Helicoverpa armigera, for use as an insect lure in a control method aimed at reducing pest damage to crops (including cotton, tomato, and green salad crops).


New method for diagnosing type 2 diabetes

13.2.2014   |   International cooperation

A Catalan research group, has found a new method to diagnose diabetes mellitus type 2 based on an epigenetic biomarker. This method has shown high specificity against diabetes type 2 over diabetes type 1 or pre diabetic subjects.


New specific biomarker for human prostate cancer prognosis

11.2.2014   |   International cooperation

An academic French laboratory developed a process based on detection of a microRNA (Ribonucleic acid molecule) as a molecular biomarker dedicated to the prognosis of cancers of the male reproductive system, including prostate cancer. This microRNA is flexible to use, non invasive and easily automatable and suitable for use on industrial scale....


Cereal grains apt for consumption by Celiac patients

7.2.2014   |   International cooperation

Researchers at the University of Seville have developed a simple process for selecting different seed varieties of wheat, barley, rye, and especially oats, which depending on whether or not they are genetically modified, can be used in gluten-free food and drink production apt for people with Celiac disease as well as excipient creation for...


A vaccine against Bovine Leukemia Virus

5.2.2014   |   International cooperation

A Belgian university team developed a recombinant Bovine Leukemia Virus (BLV) with attenuated phenotype and two specific mutations. Efficacy, persistence, safety and pathogenicity make this vaccine unique. The research team is looking for collaboration with companies interested in license agreement.


Treatment of muscular dystrophies and other disorders

3.2.2014   |   International cooperation

A Dutch medical university has developed new method that uses exon skipping in ALK4 and ALK5 for treatment of muscular dystrophies and other disorders. They are interested in collaborations with pharmaceutical and biotech companies for researching and developing treatments for muscular dystrophy.


Motor-powered nanoparticles for the delivery of molecules into cells

31.1.2014   |   International cooperation

A Spanish R&D public organization has developed nanoparticles functionalized by a carrier peptide that engages a molecule from the cell microtubule motor complex, being able to deliver a drug to its intracellular destination, enhancing its accumulation and increasing cell to cell spread.


Newly developed research grade antibodies for Epigenetics studies.

29.1.2014   |   International cooperation

The Epigenetics division of a Belgian global supplier of innovative solutions to academia, pharmaceutical and biotechnology companies is looking for license agreements from academic laboratories and research organisations that can provide already developed research antibodies to new target proteins.


Page: Previous   5 6 7 8 9 10 11 12 13 14 15 16 17   Next




  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina